Trial Profile
Prediction of efficacy to simeprevir-based triple therapy in patients with genotype 1b and high viral load
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Jun 2017
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 29 May 2017 Status changed from recruiting to completed.
- 17 Jun 2016 New trial record